Nature Reviews Urology

Article	Citations
Genomic and phenotypic heterogeneity in prostate cancer	212
Epidemiology, definition and treatment of complicated urinary tract infections	127
Epidemiology and genomics of prostate cancer in Asian men	109
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer	91
The biology and rationale of targeting nectin-4 in urothelial carcinoma	90
Could BCG be used to protect against COVID-19?	85
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19	81
Genetics of kidney stone disease	80
The immune response to infection in the bladder	77
Sarcomatoid renal cell carcinoma: biology, natural history and management	74
Sperm ion channels and transporters in male fertility and infertility	74
The need for urogenital tract monitoring in COVID-19	70
Molecular events in neuroendocrine prostate cancer development	64
The diverse roles of SPOP in prostate cancer and kidney cancer	59
Exercise-induced myokines and their effect on prostate cancer	59
Defining cisplatin eligibility in patients with muscle-invasive bladder cancer	57
Resistance to second-generation androgen receptor antagonists in prostate cancer	56
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future	55
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	50
Late adverse effects and quality of life in survivors of testicular germ cell tumour	47
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma	46
An integrated model to assess and treat compulsive sexual behaviour disorder	45
Machine learning for sperm selection	39
Current evidence on screening for renal cancer	39
Telehealth in urology after the COVID-19 pandemic	38

Understanding genomics and the immune environment of penile cancer to improve therapy	37
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer	37
Transient receptor potential channels in sensory mechanisms of the lower urinary tract	34
Making love in the time of corona — considering relationships in lockdown	33
Toilet-based continuous health monitoring using urine	33
The cognitive effect of anticholinergics for patients with overactive bladder	33
Targetable gene fusions and aberrations in genitourinary oncology	32
Treatment and trials in non-metastatic castration-resistant prostate cancer	31
Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity	30
Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer	29
Advances in sperm analysis: techniques, discoveries and applications	28
Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group	28
Human kidney stones: a natural record of universal biomineralization	28
Cannabinoid signalling and effects of cannabis on the male reproductive system	28
A global approach to improving penile cancer care	28
Bladder cancer, inflammageing and microbiomes	28
Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy	27
Spatiotemporal trends in human semen quality	27
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets	27
Pelvic organ prolapse and sexual function	27
Prostate zones and cancer: lost in transition?	26
Molecular determinants of disease severity in urinary tract infection	26
Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry	26
Salvage therapy for prostate cancer after radical prostatectomy	26
Surgical ergonomics for urologists: a practical guide	25
The potential of CAR T cell therapy for prostate cancer	25
Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function	25
Simulating nature in sperm selection for assisted reproduction	24
The dynamic roles of the bladder tumour microenvironment	23
Perspectives in primary hyperoxaluria — historical, current and future clinical interventions	23
Standardization of microbiome studies for urolithiasis: an international consensus agreement	22
Advances in the selection of patients with prostate cancer for active surveillance	21
Practical considerations for prostate hypofractionation in the developing world	21
Using PSMA imaging for prognostication in localized and advanced prostate cancer	21
Artificial intelligence in academic writing: a paradigm-shifting technological advance	21
Surgical management of high-risk, localized prostate cancer	20
Optimizing the diagnosis and management of ductal prostate cancer	20
The current role of MRI for guiding active surveillance in prostate cancer	19
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma	19
Patient-derived tumour models for personalized therapeutics in urological cancers	19
Germline testing and genetic counselling in prostate cancer	19
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	19
Roles for urothelium in normal and aberrant urinary tract development	18
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer	18
Rethinking prostate cancer screening: could MRI be an alternative screening test?	18
The multifaceted long-term effects of the COVID-19 pandemic on urology	18
Cellular senescence as a possible link between prostate diseases of the ageing male	17
Immunomodulation therapy offers new molecular strategies to treat UTI	17
Evolution of the World Health Organization semen analysis manual: where are we?	17
Introducing PIONEER: a project to harness big data in prostate cancer research	16

Regulation and role of CAMKK2 in prostate cancer	16
Animal models of naturally occurring stone disease	15
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	15
The endoplasmic reticulum stress response in prostate cancer	15
Autonomous surgery in the era of robotic urology: friend or foe of the future surgeon?	15
Immune-based therapies in penile cancer	15
Harnessing the potential of multimodal radiotherapy in prostate cancer	15
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology	14
Surgical management of primary severe hypospadias in children: an update focusing on penile curvature	14
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma	14
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs	14
Are sex disparities in COVID-19 a predictable outcome of failing men’s health provision?	14
The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant	14
Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction	13
Prostate luminal progenitor cells: from mouse to human, from health to disease	13
Considering the potential for gene-based therapy in prostate cancer	13
Depression and prostate cancer: implications for urologists and oncologists	13
Urine biomarkers in bladder cancer — current status and future perspectives	13
Sentinel lymph node biopsy using indocyanine green in penile cancer	12
Fertility preservation in boys facing gonadotoxic cancer therapy	12
Galectins as potential therapeutic targets in STIs in the female genital tract	12
MRI-guided active surveillance in prostate cancer: not yet ready for practice	12
Race and prostate cancer: genomic landscape	12
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer	12
Advances in stem cell research for the treatment of primary hypogonadism	12
The COVID-19 pandemic — what have urologists learned?	12
Experimental in vitro, ex vivo and in vivo models in prostate cancer research	12
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications	11
Organoid models of childhood kidney tumours	11
Vaccines as treatments for prostate cancer	10
Clinical use and implications of sexual devices and sexually explicit media	10
Landmarks in the evolution of prostate biopsy	10
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery	10
Advanced renal cell carcinoma and COVID-19 — a personal perspective	10
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era	10
Male infertility and somatic health — insights into lipid damage as a mechanistic link	10
Microfluidics facilitating the use of small extracellular vesicles in innovative approaches to male infertility	10
The effect of early puberty suppression on treatment options and outcomes in transgender patients	10
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations	10
Revolutionizing care for rare genitourinary tumours	9
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma	9
Current and emerging treatment options for premature ejaculation	9
Indications and characteristics of penile traction and vacuum erection devices	9
Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?	9
Genetic control of typical and atypical sex development	8
Black lives in urology: addressing the bias and redressing the balance	8
Circadian rhythm and erectile function: is there a penile clock?	8
Lessons learned from the first 15 years of penile transplantation and updates to the Baltimore Criteria	8
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration	8
Fighting the ‘other pandemic’ — systemic racism in urology	7
Pembrolizumab use in bladder cancer: a tale of two trials	7
Attention to detail and a permissive set-up: crucial for an effective TURBT	7
Obesity and prostate cancer — microenvironmental roles of adipose tissue	7
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease	7
Inheritance of paternal lifestyles and exposures through sperm DNA methylation	7
Sex differences in bladder cancer: emerging data and call to action	7
Artificial intelligence and urology: ethical considerations for urologists and patients	7
Outer membrane vesicle vaccines for Neisseria gonorrhoeae	7
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop	6
Health-related quality of life after curative treatment for muscle-invasive bladder cancer	6
Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes	6
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	5
Local anaesthetic techniques for performing transperineal prostate biopsy	5
The placebo and nocebo effects in functional urology	5
Rising Black voices in urology — the next generation	5
Human in vitro spermatogenesis as a regenerative therapy — where do we stand?	5
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo	5
The shifting treatment paradigm of metastatic renal cell carcinoma	5
The androgen receptor in bladder cancer	5
An emerging role for immuno-nutrition in patients undergoing radical cystectomy	5
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	5
AI for prostate cancer diagnosis — hype or today’s reality?	5
Supporting Black voices in urology	5
Reducing the stigma of academic mental health can save lives	5
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity	5
Calcium signalling pathways in prostate cancer initiation and progression	5
The potential role of the microbiota in prostate cancer pathogenesis and treatment	4
After COVID-19: planning postpandemic care of patients with kidney stones	4
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research	4
Is delay to radical cystectomy following BCG failure oncologically safe?	4

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?	4
The unclear role of PET–CT in localized radiorecurrent prostate cancer	4
Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade	4
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment	4
Urology teaching in UK medical schools: does it prepare doctors adequately?	4
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	4
Secondary malignancy after radiotherapy: not always a secondary concern	4
Targeting DNA repair defects in prostate cancer	4
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	4
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	4
Antibiotics impair immunotherapy for urothelial cancer	4
Barriers to the adoption and integration of patient-facing mHealth tools in urology	4
Is PFOA a renal carcinogen?	4
High-dose chemotherapy for relapsed testicular germ cell tumours	3
Treatment de-escalation for stage II seminoma	3
Uncovering a link between COVID-19 and renal cell carcinoma	3
What is fuelling the monkeypox outbreak?	3
The dawning of the age of artificial intelligence in urology	3
Genetic and biological drivers of prostate cancer disparities in Black men	3
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium	3
PROTACs for prostate cancer	3
Time for women-centred gynaecology	3
Improved phenotypic classification of male infertility to promote discovery of genetic causes	3
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancer	3
The relationship between Black men with prostate cancer and their health-care providers	3
Tracking prostate cancer development at the single-cell level	3
Serum MMP7 levels could guide metastatic therapy for prostate cancer	3
Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer	3
Genetic ancestry and racial differences in prostate tumours	3
DOT1L in prostate cancer	3
VR, reconstructive urology and the future of surgery education	3
Benefit of nectin-4 targeting with enfortumab vedotin confirmed	3
Frequency, morbidity and equity — the case for increased research on male fertility	3
Vasectomy: is the apparent decline real or not?	3
Substituting SABR for systemic therapy in oligometastatic renal cell carcinoma — buying time or time to change?	3
Principles and outcomes of gender-affirming vaginoplasty	3
Using ctDNA to guide immunotherapy for urothelial cancer	3
Predicting cancer outcomes after resection of high-risk RCC	3
PSMA PET–CT outperforms conventional imaging in high-risk prostate cancer	3
On manels and manferences in urology	2
Biomarkers of disease recurrence in stage I testicular germ cell tumours	2
Implications from autopsy studies of latent prostate cancer	2
Camrelizumab plus famitinib to treat RCC	2
Microbiota manipulation to prevent oxalate kidney stone formation	2
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC	2
Psychosocial benefits of sperm banking might outweigh costs	2
COVID and CopMich: comparing and contrasting COVID-19 experiences in the USA and Scandinavia	2
Quality of life in sexual minorities following prostate cancer treatment	2
Potency outcomes after robot-assisted radical prostatectomy	2
Pregnancy and parental leave in medicine and academia — a focus on urology	2
Building the pipeline — mentoring success in urology	2
Clinical trial design for non-muscle-invasive bladder cancer	2
The complex genetics of epigenetics in urothelial carcinomas	2
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System	2
A clinical guide to rare male sexual disorders	2
Partial gland cryoablation for prostate cancer — where are we?	2
Personalized care for male LUTS: have we attained the holy grail?	2
Patient preferences in the treatment of genitourinary cancers	2
Oligometastases: the art of providing metastases-directed therapy in prostate cancer	2
Retzius-sparing RARP: improving functional outcomes	2
Plastic exposure and urological malignancies — an emerging field	2
The prostatic middle lobe: clinical significance, presentation and management	2
Author Correction: A global approach to improving penile cancer care	2
Shared decision-making in urology and female pelvic floor medicine and reconstructive surgery	2
How to select ICSI-viable sperm from the most challenging samples	2
Smoking, ethnicity and bladder cancer — implications for public health and clinical practice	2
Bladder EpiCheck for NMIBC	2
Measuring renal function before kidney surgery — evolving towards precision in medicine	2
Sexual and reproductive health during COVID-19 — the I-SHARE multi-country survey	2
Optimizations to keep gonorrhoea treatable and reduce antimicrobial resistance selection	2
The future of patient-derived xenografts in prostate cancer research	2
Bone marrow microenvironment in prostate cancer	2
From mucosal infection to successful cancer immunotherapy	2
Management of very young fetuses with LUTO	2
Doxycycline-PEP — novel and promising but needs monitoring	2
Radical prostatectomy — aftercare should not be an afterthought	2
Novel PDL1 regulation mechanism provides opportunity for prostate cancer treatment	2
Immune infiltration associated with outcomes	1
Establishing the Bladder Cancer Research Centre at the University of Birmingham	1
Bladder-sparing neoadjuvant therapy for MIBC	1
The MURAL prostate cancer PDX collection	1
Why look back in anger? Masculinizing surgery in patients with DSD	1
Characterization of FH-deficient renal cell carcinoma	1
Patient selection is key in IMbassador250	1
Promising long-term results with proton therapy for localized prostate cancer	1
Nicardipine inhibits chemoresistance in prostate cancer	1
Effects of COVID-19 vaccine on semen parameters	1
Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction	1
Intestinal microbiota drive CRPC	1
CDH12-expressing cell population predicts patient response to therapy	1
Ibrexafungerp to treat acute vulvovaginal candidiasis	1
AR regulates CD44	1
Urine microbiota differ in bladder cancer	1
Does MRI-guided TULSA provide a targeted approach to ablation?	1
UPEC-mediated alteration of host mitochondrial function — a survival strategy	1